cGPS® (cellular Genome Positioning System) Custom technology based on meganuclease-driven homologous recombination for targeted integration in native cell lines. Enables the effortless generation of stable HepG2 isogenic clones in 36 days. Ideal for robust gene functional studies and data comparisons and for the generation of cell-based assays from laboratory's proprietary derived HepG2 clones. Can be applied to any human derived cell line.

• Selection of clones in 36 days
• 85% of targeted integration events
• stable expression >10 weeks even in the absence of selection agents